Brain inflammation targeted in first Dementia Consortium drug discovery project
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...
List view / Grid view
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...
1 June 2015 | By Victoria White
AstraZeneca and Lilly have entered into a clinical trial collaboration to evaluate MEDI4736 in combination with ramucirumab in advanced solid tumours...
15 May 2015 | By Victoria White
Eli Lilly and Company and Sanford-Burnham Medical Research Institute are to collaborate to discover and develop immunological therapies...
12 May 2015 | By Victoria White
BioNTech and Lilly are to collaborate to identify and validate novel tumour targets and their corresponding TCRs in one or more types of cancer...
11 August 2014 | By B3C newswire
FAAH Pharma Inc., announced an investment by TVM Life Science Ventures VII investment into the company.
17 June 2014 | By Boehringer Ingelheim
Boehringer Ingelheim and Eli Lilly and Company presented results of two Phase III clinical trials studying the efficacy and safety of empagliflozin...